|
|
???tair.name??? >
???browser.page.title.author???
|
"yang tsung ying"???jsp.browse.items-by-author.description???
Showing items 1-25 of 83 (4 Page(s) Totally)
1 2 3 4 > >>
View [10|25|50] records per page
| 國立成功大學 |
2023-07-11 |
動員利害關係人點燃企業成長引擎：台智雲之個案研究
|
楊宗穎; Yang, Tsung-Ying |
| 臺大學術典藏 |
2022-09-06T02:04:30Z |
Influence of the Timing of Leptomeningeal Metastasis on the Outcome of EGFR-Mutant Lung Adenocarcinoma Patients and Predictors of Detectable EGFR Mutations in Cerebrospinal Fluid
|
Liao, Pei-Ya; Ou, Wei-Fan; Su, Kang-Yi; Sun, Ming-Hsi; Huang, Chih-Mei; Chen, Kun-Chieh; Hsu, Kuo-Hsuan; SUNG-LIANG YU; Huang, Yen-Hsiang; Tseng, Jeng-Sen; Yang, Tsung-Ying; Chang, Gee-Chen |
| 臺大學術典藏 |
2022-09-06T02:02:15Z |
Characteristics and immune checkpoint inhibitor effects on non-smoking non-small cell lung cancer with KRAS mutation: A single center cohort (STROBE-compliant)
|
Wu, Jia-Jun; Lee, Po-Hsin; Zheng, Zhe-Rong; Huang, Yen-Hsiang; Tseng, Jeng-Sen; Hsu, Kuo-Hsuan; Yang, Tsung-Ying; SUNG-LIANG YU; Chen, Kun-Chieh; Chang, Gee-Chen |
| 臺大學術典藏 |
2022-09-06T01:59:43Z |
Various impacts of driver mutations on the PD-L1 expression of NSCLC
|
Chu, Cheng-Hsiang; Huang, Yen-Hsiang; Lee, Po-Hsin; Hsu, Kuo-Hsuan; Chen, Kun-Chieh; Su, Kang-Yi; SUNG-LIANG YU; Tseng, Jeng-Sen; Yang, Tsung-Ying; Chang, Gee-Chen |
| 臺大學術典藏 |
2022-09-06T01:55:22Z |
PD-L1 strong expressions affect the clinical outcomes of osimertinib in treatment naïve advanced EGFR-mutant non-small cell lung cancer patients
|
Hsu, Kuo-Hsuan; Tseng, Jeng-Sen; Yang, Tsung-Ying; Chen, Kun-Chieh; Su, Kang-Yi; SUNG-LIANG YU; Chen, Jeremy J W; Huang, Yen-Hsiang; Chang, Gee-Chen |
| 臺大學術典藏 |
2022-06-14T23:24:02Z |
Influence of the Timing of Leptomeningeal Metastasis on the Outcome of EGFR‐Mutant Lung Adenocarcinoma Patients and Predictors of Detectable EGFR Mutations in Cerebrospinal Fluid
|
Liao, Pei Ya; Ou, Wei Fan; KANG-YI SU; Sun, Ming Hsi; Huang, Chih Mei; Chen, Kun Chieh; Hsu, Kuo Hsuan; SUNG-LIANG YU; Huang, Yen Hsiang; Tseng, Jeng Sen; Yang, Tsung Ying; Chang, Gee Chen |
| 臺大學術典藏 |
2022-05-14T23:35:34Z |
The Difference in Clinical Outcomes Between Osimertinib and Afatinib for First-Line Treatment in Patients with Advanced and Recurrent EGFR-Mutant Non-Small Cell Lung Cancer in Taiwan
|
Huang, Yen Hsiang; Hsu, Kuo Hsuan; Tseng, Jeng Sen; Yang, Tsung Ying; Chen, Kun Chieh; KANG-YI SU; SUNG-LIANG YU; Chen, Jeremy J.W.; Chang, Gee Chen |
| 臺大學術典藏 |
2022-05-14T23:35:34Z |
The Clinical Outcomes of Different First-Line EGFR-TKIs Plus Bevacizumab in Advanced EGFR-Mutant Lung Adenocarcinoma
|
Huang, Yen Hsiang; Hsu, Kuo Hsuan; Chin, Chun Shih; Tseng, Jeng Sen; Yang, Tsung Ying; Chen, Kun Chieh; KANG-YI SU; SUNG-LIANG YU; Chen, Jeremy J.W.; Chang, Gee Chen |
| 臺大學術典藏 |
2022-05-12T06:47:07Z |
The Difference in Clinical Outcomes Between Osimertinib and Afatinib for First-Line Treatment in Patients with Advanced and Recurrent EGFR-Mutant Non-Small Cell Lung Cancer in Taiwan
|
Huang, Yen-Hsiang; Hsu, Kuo-Hsuan; Tseng, Jeng-Sen; Yang, Tsung-Ying; Chen, Kun-Chieh; Su, Kang-Yi; SUNG-LIANG YU; Chen, Jeremy J W; Chang, Gee-Chen |
| 臺大學術典藏 |
2022-05-12T06:43:52Z |
The Clinical Outcomes of Different First-Line EGFR-TKIs Plus Bevacizumab in Advanced EGFR-Mutant Lung Adenocarcinoma
|
Huang, Yen-Hsiang; Hsu, Kuo-Hsuan; Chin, Chun-Shih; Tseng, Jeng-Sen; Yang, Tsung-Ying; Chen, Kun-Chieh; Su, Kang-Yi; SUNG-LIANG YU; Chen, Jeremy J W; Chang, Gee-Chen |
| 臺大學術典藏 |
2022-05-12T06:04:19Z |
The Difference in Clinical Outcomes Between Osimertinib and Afatinib for First-Line Treatment in Patients with Advanced and Recurrent EGFR-Mutant Non-Small Cell Lung Cancer in Taiwan
|
Huang, Yen-Hsiang; Hsu, Kuo-Hsuan; Tseng, Jeng-Sen; Yang, Tsung-Ying; Chen, Kun-Chieh; KANG-YI SU; Yu, Sung-Liang; Chen, Jeremy J W; Chang, Gee-Chen |
| 臺大學術典藏 |
2022-05-12T05:59:04Z |
The Clinical Outcomes of Different First-Line EGFR-TKIs Plus Bevacizumab in Advanced EGFR-Mutant Lung Adenocarcinoma
|
Huang, Yen-Hsiang; Hsu, Kuo-Hsuan; Chin, Chun-Shih; Tseng, Jeng-Sen; Yang, Tsung-Ying; Chen, Kun-Chieh; KANG-YI SU; Yu, Sung-Liang; Chen, Jeremy J W; Chang, Gee-Chen |
| 臺大學術典藏 |
2022-04-14T23:27:39Z |
Association of Smoking With Patient Characteristics and Outcomes in Small Cell Lung Carcinoma, 2011-2018
|
Tseng, Jeng Sen; CHUN-JU CHIANG; Chen, Kun Chieh; Zheng, Zhe Rong; Yang, Tsung Ying; Lee, Wen Chung; Hsu, Kuo Hsuan; Huang, Yen Hsiang; Liu, Tsang Wu; Hsia, Jiun Yi; Chang, Gee Chen |
| 臺大學術典藏 |
2021-11-29T06:35:37Z |
The relative importance of predictive factors for single first-generation EGFR-TKI use for more than 5 years in patients with advanced non-small cell lung cancer: Taiwan multicenter TIPS-5 study
|
Huang, Yen-Hsiang; Hung, Jen-Yu; Ko, How-Wen; Su, Po-Lan; Lai, Chun-Liang; Chang, Huang-Chih; Hsia, Te-Chun; Lin, Sheng-Hao; Wu, Kuan-Li; Yang, Cheng-Ta; Su, Wu-Chou; Chu, Yi-Chun; Wang, Chin-Chou; Liao, Wei-Yu; YEN-TING LIN; Lin, Ching-Hsiung; Lin, Meng-Chih; Hsu, Kuo-Hsuan; Tseng, Jeng-Sen; Yang, Tsung-Ying; Chen, Kun-Chieh; Lee, Mei-Hsuan; Yu, Sung-Liang; Ho, Chao-Chi; Chang, Gee-Chen |
| 臺大學術典藏 |
2021-11-29T03:24:02Z |
The relative importance of predictive factors for single first-generation EGFR-TKI use for more than 5 years in patients with advanced non-small cell lung cancer: Taiwan multicenter TIPS-5 study
|
Huang, Yen-Hsiang; Hung, Jen-Yu; Ko, How-Wen; Su, Po-Lan; Lai, Chun-Liang; Chang, Huang-Chih; Hsia, Te-Chun; Lin, Sheng-Hao; Wu, Kuan-Li; Yang, Cheng-Ta; Su, Wu-Chou; Chu, Yi-Chun; Wang, Chin-Chou; WEI-YU LIAO; Lin, Yen-Ting; Lin, Ching-Hsiung; Lin, Meng-Chih; Hsu, Kuo-Hsuan; Tseng, Jeng-Sen; Yang, Tsung-Ying; Chen, Kun-Chieh; Lee, Mei-Hsuan; Yu, Sung-Liang; Ho, Chao-Chi; Chang, Gee-Chen |
| 臺大學術典藏 |
2021-11-10T05:29:42Z |
The impact of different first-line EGFR-TKIs on the clinical outcome of sequential osimertinib treatment in advanced NSCLC with secondary T790M
|
Huang, Yen-Hsiang; Tseng, Jeng-Sen; Hsu, Kuo-Hsuan; Chen, Kun-Chieh; KANG-YI SU; Yu, Sung-Liang; Chen, Jeremy J W; Yang, Tsung-Ying; Chang, Gee-Chen |
| 臺大學術典藏 |
2021-11-10T05:28:05Z |
Publisher Correction: The impact of different first-line EGFR-TKIs on the clinical outcome of sequential osimertinib treatment in advanced NSCLC with secondary T790M
|
Huang, Yen-Hsiang; Tseng, Jeng-Sen; Hsu, Kuo-Hsuan; Chen, Kun-Chieh; KANG-YI SU; Yu, Sung-Liang; Chen, Jeremy J W; Yang, Tsung-Ying; Chang, Gee-Chen |
| 臺大學術典藏 |
2021-11-10T03:48:58Z |
Publisher Correction: The impact of different first-line EGFR-TKIs on the clinical outcome of sequential osimertinib treatment in advanced NSCLC with secondary T790M
|
Huang, Yen-Hsiang; Tseng, Jeng-Sen; Hsu, Kuo-Hsuan; Chen, Kun-Chieh; Su, Kang-Yi; SUNG-LIANG YU; Chen, Jeremy J W; Yang, Tsung-Ying; Chang, Gee-Chen |
| 臺大學術典藏 |
2021-11-02T07:00:50Z |
The relative importance of predictive factors for single first-generation EGFR-TKI use for more than 5 years in patients with advanced non-small cell lung cancer: Taiwan multicenter TIPS-5 study
|
Huang, Yen-Hsiang; Hung, Jen-Yu; Ko, How-Wen; Su, Po-Lan; Lai, Chun-Liang; Chang, Huang-Chih; Hsia, Te-Chun; Lin, Sheng-Hao; Wu, Kuan-Li; Yang, Cheng-Ta; Su, Wu-Chou; Chu, Yi-Chun; Wang, Chin-Chou; Liao, Wei-Yu; Lin, Yen-Ting; Lin, Ching-Hsiung; Lin, Meng-Chih; Hsu, Kuo-Hsuan; Tseng, Jeng-Sen; Yang, Tsung-Ying; Chen, Kun-Chieh; Lee, Mei-Hsuan; Yu, Sung-Liang; CHAO-CHI HO; Chang, Gee-Chen |
| 臺大學術典藏 |
2021-09-14T23:18:48Z |
Publisher Correction: The impact of different first-line EGFR-TKIs on the clinical outcome of sequential osimertinib treatment in advanced NSCLC with secondary T790M (Scientific Reports, (2021), 11, 1, (12084), 10.1038/s41598-021-91657-7)
|
Huang, Yen Hsiang; Tseng, Jeng Sen; Hsu, Kuo Hsuan; Chen, Kun Chieh; KANG-YI SU; SUNG-LIANG YU; Chen, Jeremy J.W.; Yang, Tsung Ying; Chang, Gee Chen |
| 臺大學術典藏 |
2021-07-30T01:35:39Z |
Genome-Wide Epigenetic Landscape of Lung Adenocarcinoma Links HOXB9 DNA Methylation to Intrinsic EGFR-TKI Resistance and Heterogeneous Responses
|
Su, Sheng-Fang; Liu, Chia-Hsin; Cheng, Chiou-Ling; Ho, Chao-Chi; Yang, Tsung-Ying; Chen, Kun-Chieh; Hsu, Kuo-Hsuan; Tseng, Jeng-Sen; Chen, Huei-Wen; Chang, Gee-Chen; SUNG-LIANG YU; Li, Ker-Chau |
| 臺大學術典藏 |
2021-07-30T01:33:54Z |
Primary Tumor Radiotherapy During EGFR-TKI Disease Control Improves Survival of Treatment Naïve Advanced EGFR-Mutant Lung Adenocarcinoma Patients
|
Hsu, Kuo-Hsuan; Huang, Jing-Wen; Tseng, Jeng-Sen; Chen, Kuan-Wen; Weng, Yih-Chyang; SUNG-LIANG YU; Yang, Tsung-Ying; Huang, Yen-Hsiang; Chen, Jeremy J W; Chen, Kun-Chieh; Chang, Gee-Chen |
| 臺大學術典藏 |
2021-07-30T01:32:10Z |
The relative importance of predictive factors for single first-generation EGFR-TKI use for more than 5 years in patients with advanced non-small cell lung cancer: Taiwan multicenter TIPS-5 study
|
Huang, Yen-Hsiang; Hung, Jen-Yu; Ko, How-Wen; Su, Po-Lan; Lai, Chun-Liang; Chang, Huang-Chih; Hsia, Te-Chun; Lin, Sheng-Hao; Wu, Kuan-Li; Yang, Cheng-Ta; Su, Wu-Chou; Chu, Yi-Chun; Wang, Chin-Chou; Liao, Wei-Yu; Lin, Yen-Ting; Lin, Ching-Hsiung; Lin, Meng-Chih; Hsu, Kuo-Hsuan; Tseng, Jeng-Sen; Yang, Tsung-Ying; Chen, Kun-Chieh; Lee, Mei-Hsuan; SUNG-LIANG YU; Ho, Chao-Chi; Chang, Gee-Chen |
| 臺大學術典藏 |
2021-07-30T01:04:05Z |
The impact of different first-line EGFR-TKIs on the clinical outcome of sequential osimertinib treatment in advanced NSCLC with secondary T790M
|
Huang, Yen-Hsiang; Tseng, Jeng-Sen; Hsu, Kuo-Hsuan; Chen, Kun-Chieh; Su, Kang-Yi; SUNG-LIANG YU; Chen, Jeremy J W; Yang, Tsung-Ying; Chang, Gee-Chen |
| 臺大學術典藏 |
2021-07-15T05:32:06Z |
The impact of different first-line EGFR-TKIs on the clinical outcome of sequential osimertinib treatment in advanced NSCLC with secondary T790M
|
Huang, Yen Hsiang; Tseng, Jeng Sen; Hsu, Kuo Hsuan; Chen, Kun Chieh; KANG-YI SU; SUNG-LIANG YU; Chen, Jeremy J.W.; Yang, Tsung Ying; Chang, Gee Chen |
Showing items 1-25 of 83 (4 Page(s) Totally)
1 2 3 4 > >>
View [10|25|50] records per page
|
